Top Markets
Coin of the day
GH Research PLC GH Research PLC

GH Research PLC

GHRS
Rangering i aksjer #6594
GH Research PLC is a clinical-stage biopharmaceutical firm dedicated to... GH Research PLC is a clinical-stage biopharmaceutical firm dedicated to creating novel therapies for psychiatric and neurological conditions. The company primarily concentrates on developing 5-Methoxy-N,N-Dimethyltryptamine (5-MeO-DMT) treatments, specifically targeting patients with treatment-resistant depression (TRD). Its most advanced program is GH001, an inhalable 5-MeO-DMT product candidate that has successfully completed two Phase 1 clinical trials and a subsequent Phase 1/2 clinical trial in TRD patients. Additionally, GH Research is developing GH002, an injectable 5-MeO-DMT candidate, and GH003, an intranasal 5-MeO-DMT candidate. Both GH002 and GH003 are currently in preclinical development, with a focus on their potential applications in various psychiatric and neurological disorders. Founded in 2018, GH Research PLC is headquartered in Dublin, Ireland.
Aksjekurs
$28.53
Sist synkronisert: 2026-08-27
Markedsverdi
$1.96B
Endring (1 dag)
-1.65%
Endring (1 år)
106.14%
Land
IE
Handel GH Research PLC (GHRS)

Kategori

Historikk for aksjesplitt for GH Research PLC (GHRS)
Aksjen GH Research PLC (symbol: GHRS) har gjennomgått totalt 0 aksjesplitt.
Den nyeste splittelsen skjedde Aug 28, 2026.
Én GHRS-aksje kjøpt før Aug 28, 2026 tilsvarer i dag 0 GHRS-aksjer.
Liste over aksjesplitt
År Splitt Multiplikator Kumulativ multiplikator
Ikke nok data for de angitte datoene.
Aksjesplitt for lignende selskaper eller konkurrenter
Selskap Antall aksjesplitt Kumulativ multiplikator Land
1 x2
US
0 -
NL
1 x3
AU
0 -
US
0 -
CH